Haemonetics Corporation announced earnings results for the first quarter ended July 3, 2021. For the first quarter, the company announced sales was USD 228.528 million compared to USD 195.577 million a year ago. Operating income was USD 1.390 million compared to USD 11.715 million a year ago. Net loss was USD 4.454 million compared to net income of USD 10.527 million a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to diluted earnings per share from continuing operations of USD 0.21 a year ago.